Literature DB >> 15684119

The dollars and sense of drug-eluting stents.

James M Brophy1.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15684119      PMCID： PMC545760          DOI： 10.1503/cmaj.1041486

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  12 in total

1.  The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results.

Authors:  Whady Hueb; Paulo R Soares; Bernard J Gersh; Luiz A M César; Protásio L Luz; Luiz B Puig; Eulógio M Martinez; Sergio A Oliveira; José A F Ramires
Journal:  J Am Coll Cardiol       Date:  2004-05-19       Impact factor: 24.094

2.  Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials.

Authors:  Donald E Cutlip; Amit G Chhabra; Donald S Baim; Manish S Chauhan; Sachin Marulkar; Joseph Massaro; Ameet Bakhai; David J Cohen; Richard E Kuntz; Kalon K L Ho
Journal:  Circulation       Date:  2004-08-30       Impact factor: 29.690

3.  Cost-effectiveness of coronary stenting in acute myocardial infarction: results from the stent primary angioplasty in myocardial infarction (stent-PAMI) trial.

Authors:  D J Cohen; D A Taira; R Berezin; D A Cox; M C Morice; G W Stone; C L Grines
Journal:  Circulation       Date:  2001-12-18       Impact factor: 29.690

4.  Economic evaluation of sirolimus-eluting stents.

Authors:  Fiona M Shrive; Braden J Manns; P Diane Galbraith; Merril L Knudtson; William A Ghali
Journal:  CMAJ       Date:  2005-02-01       Impact factor: 8.262

5.  A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents.

Authors:  Mohan N Babapulle; Lawrence Joseph; Patrick Bélisle; James M Brophy; Mark J Eisenberg
Journal:  Lancet       Date:  2004 Aug 14-20       Impact factor: 79.321

6.  Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.

Authors:  David J Cohen; Ameet Bakhai; Chunxue Shi; Louise Githiora; Tara Lavelle; Ronna H Berezin; Martin B Leon; Jeffrey W Moses; Joseph P Carrozza; James P Zidar; Richard E Kuntz
Journal:  Circulation       Date:  2004-07-19       Impact factor: 29.690

7.  Evidence for use of coronary stents. A hierarchical bayesian meta-analysis.

Authors:  James M Brophy; Patrick Belisle; Lawrence Joseph
Journal:  Ann Intern Med       Date:  2003-05-20       Impact factor: 25.391

8.  A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators.

Authors:  A F Parisi; E D Folland; P Hartigan
Journal:  N Engl J Med       Date:  1992-01-02       Impact factor: 91.245

9.  Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

Authors:  Renu Virmani; Giulio Guagliumi; Andrew Farb; Giuseppe Musumeci; Niccolo Grieco; Teresio Motta; Laurian Mihalcsik; Maurizio Tespili; Orazio Valsecchi; Frank D Kolodgie
Journal:  Circulation       Date:  2004-01-26       Impact factor: 29.690

10.  Willingness to pay for avoiding coronary restenosis and repeat revascularization: results from a contingent valuation study.

Authors:  Dan Greenberg; Ameet Bakhai; Peter J Neumann; David J Cohen
Journal:  Health Policy       Date:  2004-11       Impact factor: 2.980
View more
  1 in total

Review 1.  The cost-effectiveness of drug-eluting stents: a systematic review.

Authors:  Suzanne Ligthart; Floortje Vlemmix; Nandini Dendukuri; James M Brophy
Journal:  CMAJ       Date:  2006-12-19       Impact factor: 8.262
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.